Remove Packaging Remove Vaccines Remove White Paper
article thumbnail

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Pharmaceutical Technology

June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. GSK has licensed altSonflex1-2-3, its Shigella vaccine candidate, to Bharat Biotech for continued development and distribution in low and middle-income nations. Credit: viewimage/Shutterstock.

article thumbnail

DoH – Abu Dhabi and Sanofi link for vaccine development

Pharmaceutical Technology

The Department of Health – Abu Dhabi (DoH) and Sanofi have signed a memorandum of understanding (MoU) to bolster vaccine development by leveraging local health-tech ecosystems and research infrastructure. Credit: Department of Health Abu Dhabi.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Navigating uncertainty: the future of vaccine oversight amid CDC firings

Pharmaceutical Technology

GlobalData Healthcare June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Changes to ACIP could result in regulatory uncertainty for vaccine developers and manufacturers. Go deeper with GlobalData Reports ESG (Environmental, Social, and Governance) in Healthcare - Themati.

article thumbnail

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? Experts praise the reforms to rare disease and antimicrobial research, but they worry that some provisions in the EU Pharma Package may harm innovation on the continent, contrary to its stated objectives.

article thumbnail

FDA approves KalVista’s Ekterly for hereditary angioedema

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 122
article thumbnail

Piramal Pharma announces $90m investment to expand US sites

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? Syngene’s expertise in the field is covered in this white paper. Syngene’s expertise in the field is covered in this white paper. You will receive an email shortly. Please check your inbox to download the Whitepaper. You will receive an email shortly.

article thumbnail

Vertex wins European approval for Alyftrek, bolstering cystic fibrosis stronghold

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.